42-X has the potential to earn $5 Billion per year. Lets look at...

42-X has the potential to earn $5 Billion per year.

Lets look at a conservative figure for OSA of $1 Billion per year for arguments sake.

Epidiolex provided GW Pharma with revenues of $570 million in 2020

Jazz paid around $6 billion for GW in May this year.

Put aside 675, TBI and GAD, conservatively what is OSA worth to say a suitor like Resmed?

Could 42-X bring about the demise of Resmed as the Internet did to Video Libraries?

I am sure the BOD of Resmed don't really want to find that out.